Cardiovascular active compounds of the general formula (I), wherein R<;SUP>;1<;/SUP>;, R<;SUP>;2<;/SUP>;, R<;SUP>;3<;/SUP>;, R<;SUP>;4<;/SUP>;, R<;SUP>;5<;/SUP>;, R<;SUP>;6<;/SUP>;, R<;SUP>;7<;/SUP>;, R<;SUP>;8<;/SUP>;, R<;SUP>;9<;/SUP>;, R<;SUP>;10<;/SUP>; and n have the meanings given in the description, and also a process for the preparation of these compounds and intermediate products of this process are described. Furthermore, pharmaceutical compositions comprising the compounds of Formula (I) are specified.